FIELD: medicine.
SUBSTANCE: invention relates to pharmaceutical industry, in particular to application of skeleton of Nocardia rubra cell wall for preparation of medication against human papilloma virus (HPV).
EFFECT: application of skeleton of Nocardia rubra cell wall ensures increase of medication safety and efficiency, simplifies application, and also reduces therapy terms and increases spectrum of medication activity.
8 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING CONDITIONS OF PROLIFERATIVE CERVICAL DISEASES | 2012 |
|
RU2503960C1 |
| METHOD FOR PREDICTING THE CLINICAL OUTCOME OF LOCALLY ADVANCED FORMS OF CERVICAL CANCER | 2018 |
|
RU2674675C2 |
| METHOD OF COMBINED THERAPY OF CERVICAL DYSPLASIA ASSOCIATED WITH HUMAN PAPILLOMA VIRUSES | 2019 |
|
RU2701525C1 |
| METHOD OF TREATING OF PLANOCELLULAR INTRAEPITHELIAL LESIONS OF CERVIX OF UTERUS | 2014 |
|
RU2552332C1 |
| MUCOSAL VACCINE FOR IMMUNE THERAPY OF DISEASES CAUSED BY HUMAN PAPILLOMA VIRUSES, AND RELATED THERAPY (VERSIONS) | 2008 |
|
RU2377305C1 |
| STABLE VECTOR OF CONSTITUTIVELY HIGH EXPRESSION FOR OBTAINING HPV VACCINE, AND RECOMBINANT LACTIC ACID BACTERIA TRANSFORMED BY THIS VECTOR | 2010 |
|
RU2492240C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DYSPLASTIC PROCESSES OF CERVIX | 2008 |
|
RU2395281C2 |
| RECOMBINANT PROTEIN CARRYING HUMAN PAPILLOMA VIRUS EPITOPES, PROTEIN EMBEDDED ADENYLATECYCLASE OR ITS FRAGMENT, ITS THERAPEUTIC APPLICATION | 2005 |
|
RU2441022C2 |
| METHOD OF COMPLEX THERAPY OF PRE-INVASIVE AND INVASIVE CERVICAL CANCER | 2013 |
|
RU2560689C2 |
| 3,3'-DIINDOLYLMETHANE (METINDOL)-BASE VAGINAL SUPPOSITORY | 2006 |
|
RU2318510C1 |
